Evrysdi

Evrysdi, a medication used to treat spinal muscular atrophy, is being recalled across the European Union due to a quality defect. The recall is classified as Class I, indicating a serious issue. People in the EU who have been prescribed this medication are affected by this recall.

Product

Active substances: risdiplam. Therapeutic area: Muscular Atrophy, Spinal. ATC code: M09AX10

Reason

Quality defect

Classification

Class I

Category

drug recall

Country

European Union

Agency

EMA-DHPC

Recall date

2026-06-12

Status

Ongoing

Distribution

European Union

Official recall notice from EMA-DHPC

Recall details on Nibble Recalls: https://trynibble.app/recalls/e20ff2f7-ab13-4b15-826e-21925b493c73